Status:
COMPLETED
Periodontal Status and Endothelial Dysfunction in Patients With Polycystic Ovary Syndrome
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Periodontal Diseases
Eligibility:
FEMALE
18-45 years
Brief Summary
Emerging research indicates a link between polycystic ovary syndrome (PCOS) and periodontal diseases, revealing the intricate relationship between oral health and systemic conditions. PCOS, a hormonal...
Detailed Description
The population will be identified using the Rotterdam criteria, which will include the following characteristics: irregular ovulation (cycles longer than 35 days or less than 26 days); elevated levels...
Eligibility Criteria
Inclusion
- Women with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria:
- Irregular ovulation (cycles longer than 35 days or less than 26 days)
- Elevated levels of free testosterone (\>0.5 ng/dl)
- Hirsutism and the presence of polycystic ovaries
- Healthy women without periodontal diseases matched in BMI and age to the PCOS group.
Exclusion
- Other systemic inflammatory conditions
- Recent antibiotic use
- Chronic anti-inflammatory use
- Cancerous or bone-affecting pathologies
- Diabetes or autoimmune diseases
- Use of any medication during the previous semester
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06184412
Start Date
February 1 2020
End Date
September 1 2022
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Doctor Peset
Valencia, Spain, 46017